OB/GYN 912 - OB/GYN Clinical Alert - Dec 01, 2005

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Subjects:

  • Neonatal Death and Morbidity in Vertex-Nonvertex Second Twins According to Mode of Delivery and Birth Weight
  • Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer
  • Surgical Management of Adnexal Torsion
  • Antenatal Betamethasone and Incidence of Neonatal Respiratory Distress After Elective Cesarean Section
  • Postmenopausal Hormone Therapy and Breast Cancer: French Cohort Study

Objectives:

  • To present the latest data regarding diagnosis and treatment of various diseases affecting women, including cancer, sexually transmitted diseases, and osteoporosis
  • To present new data concerning prenatal care and complications, as well as neonatal health
  • To discuss the pros, cons, and cost-effectiveness of new testing procedures.

Financial Disclosure:

In order to reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Leon Speroff, MD (editor) is involved as a consultant, and does research for, Wyeth Ayerst, Pfizer, Ortho, and Novo Nordisk.

Sarah L. Berga, MD (associate editor) is a consultant for Pfizer, Organon, and Women First, Inc., and is involved in research for Berlex and Health Decisions, Inc.

Robert L. Coleman, MD (associate editor) is on the speaker’s bureau for GlaxoSmithKline, Bristol Myers Squibb, and Ortho Biotech.

John C. Hobbins, MD and Frank W. Ling, MD (associate editors) report no relationships related to this field of study.

Copyright 2005 AHC Media. All rights reserved.